Systems and Methods for Radiographically Identifying an Access Port
Abstract
A power-injectable access port can include a power-injectable access port cap including an opening and a power-injectable access port base including a reservoir corresponding to the opening. The power-injectable access port can further include a septum corresponding to the reservoir. The septum can include a bottom surface covering the reservoir and a top surface extending through the opening in the power-injectable access port cap. The power-injectable access port can include a radiopaque identification feature indicating that the power-injectable access port is suitable for power injection. The radiopaque identification feature can be a suspension of a radiopaque material in a silicone material positioned on an outer surface of the power-injectable access port base. The radiopaque identification feature can have a thickness protruding from the outer surface of the power-injectable access port base such that it is perceivable by sight and touch prior to subcutaneous implantation of the power injectable access port.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A power-injectable access port, comprising:
a power-injectable access port cap including an opening; a power-injectable access port base including a reservoir corresponding to the opening in the power-injectable access port cap; a septum corresponding to the reservoir, the septum comprising a bottom surface covering the reservoir and a top surface extending through the opening in the power-injectable access port cap; and a radiopaque identification feature indicating that the power-injectable access port is suitable for power injection, the radiopaque identification feature:
comprising a suspension of a radiopaque material in a silicone material;
positioned on an outer surface of the power-injectable access port base;
having a thickness protruding from the outer surface of the power-injectable access port base such that it is perceivable by sight and touch prior to subcutaneous implantation of the power injectable access port; and
observable via imaging technology subsequent to subcutaneous implantation of the power-injectable access port.
2 . The power-injectable access port according to claim 1 , wherein the radiopaque identifier is positioned on the outer surface of the power-injectable access port base under the reservoir.
3 . The power-injectable access port according to claim 1 , wherein the radiopaque identification feature comprises one or more alphanumeric characters.
4 . The power-injectable access port according to claim 3 , wherein the one or more alphanumeric characters include the letters “C” and “T”.
5 . The power-injectable access port according to claim 4 , wherein the imaging technology includes x-ray imaging technology.
6 . The power-injectable access port according to claim 5 , wherein the power-injectable access port cap and the power-injectable access port base each comprise a bio-compatible plastic material.
7 . The power-injectable access port according to claim 6 , wherein opposing sides of the power-injectable access port cap and the power-injectable access port base are concave.
8 . The power-injectable access port according to claim 1 , wherein the radiopaque material is selected from the group consisting of tungsten, barium, titanium, and combinations thereof.
9 . The power-injectable access port according to claim 1 , wherein opposing sides of the power-injectable access port cap and the power-injectable access port base are concave.
10 . A power-injectable access port, comprising:
a power-injectable access port cap including a first opening and a second opening; a power-injectable access port base including a first reservoir corresponding to the first opening and a second reservoir corresponding to the second opening in the power-injectable access port cap; a first septum corresponding to the first reservoir, the first septum comprising a bottom surface covering the first reservoir and a top surface extending through the first opening in the power-injectable access port cap; a second septum corresponding to the second reservoir, the second septum comprising a bottom surface covering the second reservoir and a top surface extending through the second opening in the power-injectable access port cap; a first radiopaque identification feature indicating that the power-injectable access port is suitable for power injection, the first radiopaque identification feature:
comprising a suspension of a radiopaque material in a silicone material;
positioned on an outer surface of the power-injectable access port base below the first reservoir;
having a thickness protruding from the outer surface of the power-injectable access port base such that it is perceivable by sight and touch prior to subcutaneous implantation of the power injectable access port; and
observable via imaging technology subsequent to subcutaneous implantation of the power-injectable access port; and
a second radiopaque identification feature indicating that the power-injectable access port is suitable for power injection, the second radiopaque identification feature:
comprising a suspension of a radiopaque material in a silicone material;
positioned on an outer surface of the power-injectable access port base below the second reservoir;
having a thickness protruding from the outer surface of the power-injectable access port base such that it is perceivable by sight and touch prior to subcutaneous implantation of the power injectable access port; and
observable via imaging technology subsequent to subcutaneous implantation of the power-injectable access port.
11 . The power-injectable access port according to claim 1 , wherein one of the first radiopaque identification feature and the second radiopaque identification feature comprises one or more alphanumeric characters.
12 . The power-injectable access port according to claim 11 , wherein the one or more alphanumeric characters include the letters “C” and “T”.
13 . The power-injectable access port according to claim 12 , wherein the imaging technology includes x-ray imaging technology.
14 . The power-injectable access port according to claim 13 , wherein the power-injectable access port cap and the power-injectable access port base each comprise a bio-compatible plastic material.
15 . The power-injectable access port according to claim 14 , wherein opposing sides of the power-injectable access port cap and the power-injectable access port base are concave.
16 . The power-injectable access port according to claim 10 , wherein the radiopaque material is selected from the group consisting of tungsten, barium, titanium, and combinations thereof.
17 . The power-injectable access port according to claim 10 , wherein each of the first radiopaque identification feature and the second radiopaque identification feature comprises one or more alphanumeric characters.
18 . The power-injectable access port according to claim 17 , wherein the one or more alphanumeric characters include the letters “C” and “T”.
19 . The power-injectable access port according to claim 18 , wherein the power-injectable access port cap and the power-injectable access port base each comprise a bio-compatible plastic material.
20 . The power-injectable access port according to claim 19 , wherein opposing sides of the power-injectable access port cap and the power-injectable access port base are concave.Join the waitlist — get patent alerts
Track US2021077801A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.